◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

GSK plc ADRhedged (GSKH) ETF Overview

Name: GSK plc ADRhedged (GSKH) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · Health · DATA UPDATED 2026-08-31

GSK plc ADRhedged (GSKH) is an exchange-traded fund managed by ADRH in the "Health" category. It manages roughly $1 million in assets.

The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of GSK plc (the “Company”). The series will not invest directly in the company. The fund is non-diversified.

Interactive chart & fund stats →

GSKH Fund Statistics

Expense ratio	0.19%
Trailing yield	1.59%
Assets under management	$1 million
Fund category	Health
Fund family	ADRH
Inception	2025-01-06

The live price chart, fund profile and news are in the interactive GSKH viewer.

Other Companies in Health

GNMX · Corgi Genomics & Precision Medicine ETF — $2 million
ASD · Defiance Autism Impact ETF — $1 million
MHIP · Milliman Healthcare Inflation Plus ETF — $1 million
TRUH · Vaneck Healthcare TruSector ETF — $1 million
XLV · State Street Health Care Select Sector SPDR ETF — $42 billion
VHT · Vanguard Health Care Index Fund ETF Shares — $21 billion
XBI · State Street SPDR S&P Biotech ETF — $10 billion
IBB · iShares Biotechnology ETF — $9 billion

← GSK All “G” companies GSL →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.